Takahiko Saida

PS-52-10 Histopathological and electrophysiological findings in experimental allergic neuritis induced by a synthetic peptide of human myelin P2 protein

Ryuji Kaji, Jun Kimura, Ichiro Akiguchi, 1995 .

S-3-2 Roles of glycolipids antibodies and infectious agents in immune-mediated neuropathies

Qi Hao, Hiroshi Obayashi, Takahiko Saida, 1995 .

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

Ludwig Kappos, Jan Hillert, Gilles Edan, 2007, The Lancet Neurology.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.